Efforts to contain drug-resistant malaria near Thai-Cambodian border appear to be working, officials say

A two-year effort aimed at preventing the emergence of drug-resistant malaria near the border between Cambodia and Thailand is showing signs of success, Duong Socheat, head of Cambodia's National Center for Malaria Control, said on Friday, DPA/Earth Times reports.

So far, 2,448 people have been tested near the town of Pailin, but only two cases of malaria resistant to artemisinin combination therapy (ACT) have been identified, Socheat said, adding that the result was "encouraging." The six-week program tested people in six of the country's "most malaria-prone villages," the news service writes.

"Two years ago the government, the World Health Organization (WHO) and several NGOs combined efforts to tackle the resistant falciparum strain that was discovered in 2007 ... The ongoing process to test villagers follows a concerted effort around Pailin against ACT-resistant malaria, that included providing mosquito nets, combating fake drugs and educating people. Nationwide 1,300 villages now have two health workers trained to test for malaria and provide free treatment," DPA/Earth Times notes. 

Steven Bjorge, a WHO malaria specialist in Phnom Penh, "It looks like we are having success. I am cautiously optimistic." Socheat said he is hopeful that the government goal of zero malaria deaths by 2020 can be be achieved if the appropriate funding and expertise continues to be provided. Just recently, the U.S. global malaria coordinator "told a conference in Hanoi there were indications that ACT-resistant malaria had emerged in Myanmar and Vietnam" (6/25).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UNICEF delivers first R21/Matrix-M malaria vaccine doses to Central African Republic